… the brain of neurotoxic blood-… brain and post-mortem tissue as well as biomarker studies
demonstrating BBB breakdown in Alzheimer disease, Parkinson disease, Huntington disease, …

… Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by the …
brain inflammation, which promotes disease pathogenesis. In this context, the blood-brain barrier …

… genic mice, and post-mortem brain tissue have advanced our understanding of Alzheimer
disease (AD). However, the molecular pathogenesis of the disease is still not clear, and we …

… Blood-brain barrier (BBB) regulates transport of various molecules and maintains brain …
have been implicated in the pathogenesis of Alzheimer disease (AD). Although receptor for …

… diseases of the CNS, such as multiple sclerosis and AD, changes in blood composition,
brain inflammation and the facilitated entrance of immune cells through the brain barriers can …

… Conclusions: Blood–brain barrier (BBB) impairment is a stable characteristic over 1 year
and present in an important subgroup of patients with Alzheimer disease. Age, gender, APOE …

Purpose To investigate whether the blood-brain barrier (BBB) leaks blood-circulating substances
in patients with early forms of Alzheimer disease (AD), and if so, to examine the extent …

… blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's
disease … Amyloid-β peptide as a vaccine for Alzheimer's disease involves receptor-mediated …

The blood–brain barrier (BBB) plays critical roles in the maintenance of central nervous
system (CNS) homeostasis. Dysfunction of the BBB occurs in a number of CNS diseases, …

The blood-brain barrier (BBB) is involved in the pathogenesis of Alzheimer’s disease (AD).
BBB is a highly selective semipermeable structural and chemical barrier which ensures a …